M&A / Deals Aditxt and Ignite announce merger plans with strategic partner Pharmaceutical TechnologyAditxt and subsidiary Ignite Proteomics have announced plans for a business combination with a strategic partner.Read full story pharminent June 10, 2026 (Last updated: June 10, 2026) Pharmaceutical Technology Aditxt and subsidiary Ignite Proteomics have announced plans for a business combination with a strategic partner. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Cancer biotech Parabilis books record IPO, raising $670mNext: AbbVie’s migraine drug cleared for migraine attacks on NHS Related Stories M&A / Deals Zymeworks cuts deal to buy Theravance for $929m in cash pharminent June 29, 2026 M&A / Deals Ipsen charts $1.75bn course for Kartos acquisition pharminent June 29, 2026 M&A / Deals Immunai and Boehringer partner to identify T-cell targets pharminent June 26, 2026
